Treatment of prediabetic patients with insulin: Experience and future

Hormone Research in Paediatrics

Volumn 45, Issue , 1996, Pages 44-47

  Caret, J C ^a   Bougneres P F ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Diabetes; Insulin; Insulin immunization; Prediabetes

Indexed keywords

INSULIN; INSULIN ZINC SUSPENSION;

CELL DESTRUCTION; CELL FUNCTION; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROPHYLAXIS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PREDIABETIC STATE;

EID: 0029924930     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000184829     Document Type: Article

References (19)

1. Schloot N, Eiscnbarth GS: Isohormonal therapy of endocrine autoimmunity. Immunol Today 1995;16:289-294.
2. Gladstone P, Nepom GT: The prevention of IDDM. Injecting insulin into the cytokine network. Diabetes 1995;44:859-862.
3. Atkinson MA, Maclaren NK, Luchetta R: lnsu-litis and diabetes in NOD mice reduccd by prophylactic insulin therapy. Diabetes 1990:39: 933-937.
4. Thivolet CH, Goiilot E, Durand A, Bonnard M, Orgiazzi J: Insulin prevents adoptive transfer of diabetes in the autoimmune non-obese diabetic mouse. Diabetologia 1991;34:314—319.
5. Muir A, Peck A, Clarc-Salzlcr M, Song YH, Cornelius J, Luchetta R, Krischcr JP, Maclaren NK: Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gam-ma transcription. J Clin Invest 1995;95:628-634.
6. Zhang ZJ, Davidson L, Eiscnbarth GS, Weiner HL: Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991;88: 10252-10256.
7. Hutchings PR, Cooke A: Comparative study of the protective effect afforded by intravenous administration of bovine or ovine insulin to young NOD mice. Diabetes 1995;44:906-910.
8. Godfredson GF, Buschard K, Frandsen EK: Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 1985:28: 933-935.
9. Like AA: Insulin injections prevent diabetes in BioBreeding AVorcestcr rats. Diabetes 1986: 35(suppl l):74A.
10. Gottlieb PA, Handler ES, Appel MC, Greiner DL, Mordes JP, Rossini AA: Insulin treatment prevents diabetes mcllitus but not thyroiditis in RT6-depleted diabetes resistant BBWor rats. Diabetologia 1991:34:296-300.
11. Muir A, Luchetta R, Schatz D: Insulin-specific immunotherapy ameliorates diabetes in non-obese diabetic (NOD) mice. Diabetes 1992: 4l(suppl 1):39A.
12. Vardi P, Dibclla EE, Pasquarcllo TJ, Srikanta S: Islet cell autoantibodies: Pathobiologv and clinical applications. Diabetes Care 1987; 10: 645-656.
13. Wegmann DR, Norbury Glaser M, Daniel D: Insuln-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 1994;24:1853-1857.
14. Wegmann DR, Gill RG, Norbury Glaser M, Schloot N, Daniel D: Analysis of the spontaneous T cell response to insulin in NOD mice. J Autoimmun 1994:7:833-843.
15. Shah SC, Malone JL, Simpson NE: A randomized Irial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes. N Engl J Med 1989;320:550-554.
16. Keller RJ, Eiscnbarth GS, Jackson RA: Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 1993;341:927-928.
17. Ziegler AG, Bachmann MF, Rabl W: Prophylactic insulin treatment in relatives at high risk for type 1 diabetes. Diabetes Metab Rev 1993: 9:289-293.
18. Bock T, Pedersen CR, Josefsen K, Botazzo GF, Palmer JP, Buschard K: No risk of diabetes after insulin-shock treatment. Lancet 1992: 339:1504-1506.
19. Bennett Johnson S, Tcrcyak KP: Psychological impact of islet cell antibody screening for IDDM on children, adults, and their family members. Diabetes Care 1996. in press.